Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics.
作者信息
Ramadas Smitha, Krishnan Jijith, Andrade Chittaranjan
机构信息
Dept. of Psychiatry, Government Medical College, Thrissur, Kerala, India.
Dept. of General Medicine, Government Medical College, Thrissur, Kerala, India.
出版信息
Indian J Psychol Med. 2023 Jan;45(1):92-94. doi: 10.1177/02537176221099307. Epub 2022 Jun 26.
Abstract
摘要
相似文献
1
Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics.低剂量锂盐所致的神经阻滞剂恶性综合征，无抗精神病药物联用情况
Indian J Psychol Med. 2023 Jan;45(1):92-94. doi: 10.1177/02537176221099307. Epub 2022 Jun 26.
2
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].[抗精神病药恶性综合征与非典型抗精神病药物：简要综述]
Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.
3
Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database.典型和非典型抗精神病药物引起的神经阻滞剂恶性综合征的死亡率：来自日本诊断程序组合数据库的倾向匹配分析。
J Clin Psychiatry. 2012 Apr;73(4):427-30. doi: 10.4088/JCP.10m06791. Epub 2011 Nov 1.
4
Neuroleptic Malignant Syndrome Associated with Lithium Toxicity.与锂中毒相关的抗精神病药恶性综合征
Oman Med J. 2016 Jul;31(4):309-11. doi: 10.5001/omj.2016.59.
5
Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.新型抗精神病药物与神经阻滞剂恶性综合征：综述与评论
Am J Psychiatry. 1998 Aug;155(8):1113-6. doi: 10.1176/ajp.155.8.1113.
6
Reinduction of neuroleptic malignant syndrome by lithium.
J Clin Psychopharmacol. 1987 Oct;7(5):339-41.
7
Subcortical Structure Disruption in Diffusion Tensor Tractography of the Patient With the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity Combined With Neuroleptic Malignant Syndrome: A Case Report.不可逆性锂效应神经毒性合并神经阻滞剂恶性综合征患者的弥散张量纤维束成像的皮质下结构破坏：病例报告。
Clin Neuropharmacol. 2021;44(2):62-67. doi: 10.1097/WNF.0000000000000439.
8
Side effects of antipsychotic agents--neuroleptic malignant syndrome.抗精神病药物的副作用——神经阻滞剂恶性综合征
Med Pregl. 2010 Sep-Oct;63(9-10):705-8. doi: 10.2298/mpns1010705c.
9
Pathogenesis and treatment of neuroleptic malignant syndrome.抗精神病药恶性综合征的发病机制与治疗
Gen Pharmacol. 1990;21(4):367-86. doi: 10.1016/0306-3623(90)90685-f.
10
A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use.锂中毒和使用阿立哌唑背景下的神经阻滞剂恶性综合征 1 例
Clin Neuropharmacol. 2024;47(1):22-25. doi: 10.1097/WNF.0000000000000575. Epub 2023 Oct 23.
引用本文的文献
1
Long prodromal symptoms of neuroleptic malignant syndrome in patient with intellectual developmental disorder-A case report.精神发育迟滞患者中抗精神病恶性综合征的长前驱症状：病例报告。
Neuropsychopharmacol Rep. 2024 Sep;44(3):521-525. doi: 10.1002/npr2.12454. Epub 2024 Jun 4.
2
Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk.一名被监禁患者的非典型抗精神病药恶性综合征：这是一个可能风险增加的人群。
BMJ Case Rep. 2024 Feb 6;17(2):e257563. doi: 10.1136/bcr-2023-257563.
3
The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome.抗精神病药和其他药物在神经阻滞剂恶性综合征的发展和进展中的作用。
Sci Rep. 2023 Oct 27;13(1):18459. doi: 10.1038/s41598-023-45783-z.
本文引用的文献
1
Neuroleptic Malignant Syndrome in a Patient with Lithium-induced Nephrogenic Diabetes Insipidus: A Case Report.一例锂诱导性肾性尿崩症患者发生的抗精神病药恶性综合征：病例报告
Indian J Psychol Med. 2023 Jan;45(1):91-92. doi: 10.1177/02537176211045621. Epub 2021 Oct 8.
2
Neuroleptic Malignant Syndrome Associated with Lithium Toxicity.与锂中毒相关的抗精神病药恶性综合征
Oman Med J. 2016 Jul;31(4):309-11. doi: 10.5001/omj.2016.59.
3
Neuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidol.一名接受碳酸锂和氟哌啶醇治疗的患者出现神经阻滞剂恶性综合征。
Shanghai Arch Psychiatry. 2014 Dec;26(6):368-70. doi: 10.11919/j.issn.1002-0829.214099.
4
Lithium-induced fatal neuroleptic malignant syndrome in a patient not being concomitantly treated with commonly offending agents.锂诱导的致命性神经阻滞剂恶性综合征，发生在未同时使用常见致病药物治疗的患者身上。
J Pain Symptom Manage. 2012 Dec;44(6):e4-6. doi: 10.1016/j.jpainsymman.2012.08.010.
5
Lithium-induced paradoxical neurotoxicity-a risk factor.锂诱导的矛盾性神经毒性——一个风险因素。
Indian J Psychiatry. 1988 Apr;30(2):201-3.
6
Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neuroleptic.联合应用锂剂和神经阻滞剂治疗时神经阻滞剂恶性综合征的发生风险增加。
Indian J Psychiatry. 1997 Jul;39(3):251-5.
7
Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.与非典型抗精神病药物相关的神经阻滞剂恶性综合征。
CNS Drugs. 2009;23(6):477-92. doi: 10.2165/00023210-200923060-00003.
8
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
9
Spectrum concept of neuroleptic malignant syndrome.
Br J Psychiatry. 1988 Jul;153:107-11. doi: 10.1192/bjp.153.1.107.
10
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Am J Psychiatry. 1985 Oct;142(10):1137-45. doi: 10.1176/ajp.142.10.1137.
Zotero 插件